RT @yourICM: My paper 20 years later: NIV in immunocompromized pts. Pooled analysis shows: a decrease in mortality (RR 0.68, 95% CI 0.53–0.…
RT @yourICM: My paper 20 years later: NIV in immunocompromized pts. Pooled analysis shows: a decrease in mortality (RR 0.68, 95% CI 0.53–0.…
RT @yourICM: My paper 20 years later: NIV in immunocompromized pts. Pooled analysis shows: a decrease in mortality (RR 0.68, 95% CI 0.53–0.…
RT @yourICM: My paper 20 years later: NIV in immunocompromized pts. Pooled analysis shows: a decrease in mortality (RR 0.68, 95% CI 0.53–0.…
RT @yourICM: My paper 20 years later: NIV in immunocompromized pts. Pooled analysis shows: a decrease in mortality (RR 0.68, 95% CI 0.53–0.…
RT @yourICM: My paper 20 years later: NIV in immunocompromized pts. Pooled analysis shows: a decrease in mortality (RR 0.68, 95% CI 0.53–0.…
RT @yourICM: My paper 20 years later: NIV in immunocompromized pts. Pooled analysis shows: a decrease in mortality (RR 0.68, 95% CI 0.53–0.…
RT @yourICM: My paper 20 years later: NIV in immunocompromized pts. Pooled analysis shows: a decrease in mortality (RR 0.68, 95% CI 0.53–0.…
RT @yourICM: My paper 20 years later: NIV in immunocompromized pts. Pooled analysis shows: a decrease in mortality (RR 0.68, 95% CI 0.53–0.…
RT @yourICM: My paper 20 years later: NIV in immunocompromized pts. Pooled analysis shows: a decrease in mortality (RR 0.68, 95% CI 0.53–0.…
RT @yourICM: My paper 20 years later: NIV in immunocompromized pts. Pooled analysis shows: a decrease in mortality (RR 0.68, 95% CI 0.53–0.…
RT @yourICM: My paper 20 years later: NIV in immunocompromized pts. Pooled analysis shows: a decrease in mortality (RR 0.68, 95% CI 0.53–0.…
RT @yourICM: My paper 20 years later: NIV in immunocompromized pts. Pooled analysis shows: a decrease in mortality (RR 0.68, 95% CI 0.53–0.…
RT @yourICM: My paper 20 years later: NIV in immunocompromized pts. Pooled analysis shows: a decrease in mortality (RR 0.68, 95% CI 0.53–0.…
RT @yourICM: My paper 20 years later: NIV in immunocompromized pts. Pooled analysis shows: a decrease in mortality (RR 0.68, 95% CI 0.53–0.…
RT @yourICM: My paper 20 years later: NIV in immunocompromized pts. Pooled analysis shows: a decrease in mortality (RR 0.68, 95% CI 0.53–0.…
RT @yourICM: My paper 20 years later: NIV in immunocompromized pts. Pooled analysis shows: a decrease in mortality (RR 0.68, 95% CI 0.53–0.…
RT @yourICM: My paper 20 years later: NIV in immunocompromized pts. Pooled analysis shows: a decrease in mortality (RR 0.68, 95% CI 0.53–0.…
RT @yourICM: My paper 20 years later: NIV in immunocompromized pts. Pooled analysis shows: a decrease in mortality (RR 0.68, 95% CI 0.53–0.…
My paper 20 years later: NIV in immunocompromized pts. Pooled analysis shows: a decrease in mortality (RR 0.68, 95% CI 0.53–0.88), less need for intubation (RR 0.71, 95% CI 0.58–0.87) and lower rates of nosocomial pneumonia (RR 0.39, 95% CI 0.20–0.76) htt
My paper 20 years later: NIV in immunocompromized patients https://t.co/5MhfWxtpaY #IntCareMed